Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mallinckrodt PLC (MNK) Looks Appealing To This Billionaire Despite Its Slump

Page 1 of 2

After increasing its stake in Mallinckrodt PLC (NYSE:MNK) by 54% during the second quarter, a recently submitted 13G shows that billionaire Andreas Halvorsen‘s Viking Global has purchased an additional 311,530 shares of the company. With this purchase, Viking Global’s stake in the company now stands at slightly over 5.72 million shares or 4.87% of the outstanding shares of the company. Even though Viking Global has upped its stake, due to the recent slump in Mallinckrodt PLC (NYSE:MNK)’s stock, the current value of its position in the company stands at $494.14 million, far less than the $637.53 million that it was worth at the end of June.

Andreas Halvorsen

Andreas Halvorsen founded Viking Global, a Greenwich, Connecticut-based  long/short equity hedge fund in 1999, along with Brian Olson (who left the fund in 2005) and David Ott (who left the fund in 2010). Before starting Viking Global, the trio of Halvorsen, Olson, and Ott used to work for hedge fund legend Julian Robertson’s Tiger Management. Due to the 13.4% percent return Viking had in 2014 and the almost 18% annual returns the fund has generated for its investors since its inception, Andreas Halvorsen has emerged as one of the most successful proteges, or ‘Tiger Cubs’ of Robertson. In March of this year, the fund announced that its longtime executive and CIO, Tom Purcell, who has been with Viking since 1999, will be leaving the fund. According to the latest figures, Viking currently boasts assets under management in excess of $32 billion and its U.S public equity portfolio at the end of June stood at $26.47 billion.

Andreas Halvorsen
Andreas Halvorsen
Viking Global

Professional investors like Halvorsen spend considerable time and money conducting due diligence on each company they invest in, which makes them the perfect investors to emulate. However, we also know that the returns of hedge funds on the whole have not been good for several years, underperforming the market. We analyzed the historical stock picks of these investors and our research revealed that the small-cap picks of these funds performed far better than their large-cap picks, which is where most of their money is invested and why their performances as a whole have been poor. Why pay fees to invest in both the best and worst ideas of a particular hedge fund when you can simply mimic the best ideas of the best fund managers on your own? A portfolio consisting of the 15 most popular small-cap stock picks among the funds we track has returned 118% and beaten the market by more than 60 percentage points since the end of August 2012 (see the details).

Mallinckrodt PLC (NYSE:MNK) is an Ireland-based multibillion-dollar specialty biopharmaceutical company. It came into existence in 2013 when its erstwhile owner Covidien plc (NYSE:COV) decided to spin off its pharmaceutical business into a separate publicly-traded company. Shares of Mallinckrodt PLC (NYSE:MNK) witnessed a glorious uptrend after its debut on the market and until just recently, were trading at more than three times the price they made their debut on the NYSE at. However, due to the dismal fiscal 2015 third quarter numbers reported by the company recently, its shares have fallen by more than 30% since then. Apart from Viking Global, Mallinckrodt PLC (NYSE:MNK)  counted John Paulson‘s Paulson & Co and Neal C. Bradsher‘s Broadwood Capital among its largest shareholders during the second quarter. At the end of June, Paulson & Co owned almost 6.6 million shares and Broadwood Capital owned over 1.6 million shares of the company.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!